Trending Topic

3d medical x ray of knee pain with arthritis inflammation and tendon injury, copy space
9 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

The use of immune checkpoint inhibitors (ICIs) in treating cancer has greatly improved survival outcomes, particularly in patients with advanced disease for whom successful treatment options have previously been limited. For example, in patients with metastatic melanoma, the median survival time has improved from just 6 months to approximately 6 years with the use of […]

Xenofon Baraliakos, ACR 2020 -Clinical Response Time Frame in Axial Spondyloarthritis Treated with Etanercept

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Nov 24th 2020
Xenofon Baralikos (Ruhr-University, Bochum, Germany) discusses with touchIMMUNOLOGY the findings from the post hoc analysis of 4 RCT trials investigating the time frames of clinical response in patients with axial spondyloarthritis receiving etanercept.
His abstract ‘Temporal Achievement of Clinical Response and Inactive Disease Status in Patients with Axial Spondyloarthritis Treated with Etanercept’ (ABSTRACT NUMBER: 0897) was presented at ACR Convergence 2020, 5-9 November.
Questions
  1. Where does etanercept sit in the treatment paradigm for patients with axial spondyloarthritis? (0:15)
  2. What were the aims of your recent analysis of data from studies evaluating the safety and efficacy of etanercept in the treatment of patients with axial spondyloarthritis? (1:14)
  3. What were the findings of the study and what factors determined an early response? (2:23)
  4. What are the implications of these findings for clinical practice? (4:19)

Disclosures: Xenofon Baralikos has nothing to disclose in relation to this video interview.

Support:  Interview and filming supported by Touch Medical Media Ltd.

Filmed in coverage of virtual ACR Convergence 2020.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup